Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rofecoxib in Patients with Mild Cognitive Impairment: Further Analyses of Data from a Randomized, Double-Blind, Trial

Published:2008-02-01 Issue:1 Volume:5 Page:73-82
ISSN:1567-2050
Container-title:Current Alzheimer Research
language:en
Short-container-title:CAR

Author:

Aisen Paul,Thal Leon,Ferris Steven,Assaid Christopher,Nessly Michael,Giuliani Michael,Lines Christopher,Norman Barbara,Potter William

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Neurology,Neurology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin Therapy, Cognitive Impairment, and Dementia—A Review;Future Pharmacology;2023-02-01

2. Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing;Pharmaceuticals;2022-07-03

3. Impact of a Novel Anti-Inflammatory Ketoprofen-Lysine Prodrug on Cerebral Pathology and Cognition in a Comorbid APP21 Transgenic Rat with Diet-Induced Metabolic Syndrome;SSRN Electronic Journal;2022

4. Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases;Current Medicinal Chemistry;2019-09-02

5. Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery;Nitric Oxide;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP